Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories Q2 consolidated net profit climbs 70%
>>
Dr. Reddy's Lab gets approval for Aspirin, extended-release Dipyridamole Capsules
>>
Dr. Reddy’s Lab surges on the bourses
>>
Dr. Reddy’s Lab sells Jeedimetla API manufacturing business unit to Therapiva
>>
Dr. Reddy’s Lab soars on launching Colesevelam HCI Tablets
>>
Dr. Reddy’s Lab launches Colesevelam HCI Tablets
>>
Dr Reddy's recalls around 70,000 vials of Zoledronic acid injection from US
>>
Dr. Reddy's Lab’s arm sells rights of Cloderm Cream to EPI Health
>>
Dr. Reddy’s Lab sells its antibiotic manufacturing site, related assets in Bristol
>>
Dr. Reddy's Lab regains worldwide rights to DFA-02
<<
<
74
75
76
...143
>
>>